EFFECT OF ACUTE ELEVATION OF FFA ON MITOCHONDRIAL FUNCTION IN SKELETAL MUSCLE
EFFECT OF ACUTE ELEVATION OF FFA ON MITOCHONDRIAL FUNCTION IN SKELETAL MUSCLE
批准号:
7718697
负责人:
RALPH A DEFRONZO
金额:
$0.09万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2008-05-31
关键词:
ATP Synthesis PathwayAcuteAddressAnalysis of VarianceBiopsyComputer Retrieval of Information on Scientific Projects DatabaseConfocal MicroscopyDevelopmentDiabetes MellitusElectron MicroscopyElectron TransportElevationEnd PointFamily history ofFundingGenerationsGlucoseGrantHourInfusion proceduresInstitutionInsulinInsulin ResistanceLinear ModelsLipidsLiposynMeasuresMembrane PotentialsMethodsMitochondriaMorphologyNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsPathogenesisPlasmaRateReactive Oxygen SpeciesResearchResearch PersonnelResourcesSalineSkeletal MuscleSourceUnited States National Institutes of HealthWeekdesignenzyme activitymitochondrial dysfunctionmitochondrial membrane
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
BACKGROUND: Insulin resistance is a primary component of type 2 diabetes mellitus (T2DM) and is present long before the development of diabetes. Elevated plasma free fatty acid concentrations (FFA) and increased intracellular metabolites of FFA are believed to contribute to the pathogenesis of insulin resistance. Recently, it has also been proposed that elevated plasma FFA and intracellular FFA metabolites are a result of mitochondrial dysfunction. However, it is not clear whether elevated FFA concentrations seen in type 2 diabetes and other insulin resistant states are a result of mitochondrial dysfunction or whether they cause insulin resistance by impairing mitochondrial function. To address this issue, we propose to study whether short term elevation of the plasma FFA concentration in healthy subjects induces mitochondrial dysfunction.
STUDY HYPOTHESIS: Increased intracellular lipids inhibit ATP synthesis in the skeletal muscle and induce the formation of reactive oxygen species.
STUDY DESIGN: Healthy glucose tolerant subjects without family history of type 2 diabetes will participate in two euglycemic insulin clamp studies performed with an interval of 4-6 weeks: (Study 1) 20% Liposyn will be infused at a rate of 60 ml/hour for 7 hours to elevate the plasma FFA concentration and a euglycemic insulin clamp will be performed during hours 4-7; (Study 2) saline infusion at 60 ml/hour for 7 hours and a euglycemic insulin clamp will be performed during hours 4-7. Mitochondrial function will be assessed from skeletal muscle biopsies performed before, and at 4 and 7 hours after lipid/saline infusion to examine the effect of lipids elevated plasma lipid on skeletal muscle mitochondrial function before and after insulin clamp. Mitochondrial ATP synthesis, oxidative enzyme activity, electron transport chain capacity, and reactive oxygen species (ROS) generation will be assessed by confocal microscopy and enzymatic methods and mitochondrial morphology will be determined by electron microscopy.
Primary Endpoint - Insulin stimulated ATP synthesis rate and ROS generation.
Statistical Analysis - Mitochondrial membrane potential which reflects the rate of ATP synthesis, and ROS generation will be compared between baseline versus 4 and 7 hours of saline and lipid infusion, using the analysis of variance (ANOVA) or mixed linear model with repeated measures, where the repeated measures are those after 4 and 7 hours as well as those with lipid infusion and without lipid infusion (saline).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
-
批准号:10601098
-
项目类别:
-
资助金额:$68.22万
-
财政年份:2022
-
负责人:RALPH A DEFRONZO
-
依托单位:
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
-
批准号:10446388
-
项目类别:
-
资助金额:$69.59万
-
财政年份:2022
-
负责人:RALPH A DEFRONZO
-
依托单位:
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
-
批准号:10595032
-
项目类别:
-
资助金额:$64.73万
-
财政年份:2016
-
负责人:RALPH A DEFRONZO
-
依托单位:
SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION
-
批准号:9032300
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:RALPH A DEFRONZO
-
依托单位:
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
-
批准号:10713358
-
项目类别:
-
资助金额:$6.21万
-
财政年份:2016
-
负责人:RALPH A DEFRONZO
-
依托单位:
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
-
批准号:10632818
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2016
-
负责人:RALPH A DEFRONZO
-
依托单位:
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
-
批准号:10445180
-
项目类别:
-
资助金额:$66.11万
-
财政年份:2016
-
负责人:RALPH A DEFRONZO
-
依托单位:
Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM
-
批准号:9130823
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2015
-
负责人:RALPH A DEFRONZO
-
依托单位:
Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM
-
批准号:8965261
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2015
-
负责人:RALPH A DEFRONZO
-
依托单位:
Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM
-
批准号:9324995
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2015
-
负责人:RALPH A DEFRONZO
-
依托单位:
Regulation of Hepatic and Peripheral Glucose Metabolism
-
批准号:8000968
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2009
-
负责人:RALPH A DEFRONZO
-
依托单位:
Improved Hypoglycemia Rescue Device
-
批准号:8335392
-
项目类别:
-
资助金额:$57.65万
-
财政年份:2009
-
负责人:RALPH A DEFRONZO
-
依托单位:
Improved Hypoglycemia Rescue Device
-
批准号:8203897
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2009
-
负责人:RALPH A DEFRONZO
-
依托单位:
PROT 1: EFFECT OF PHYSIOLOGIC INCREASE IN FFA ON MITOCHONDRIAL FUNC IN NGT SUBJ
-
批准号:7718701
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
GLYCEMIC CONTROL AND COMPLICATIONS IN DIABETES MELLITUS TYPE 2
-
批准号:7718688
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
PROTOCOL V: EFFECT OF CHRONICALLY ELEVATED PLASMA FFA ON HGP AND GLUCONEOGENESIS
-
批准号:7718687
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
CLINICAL TRIAL: EFFECTS OF 8 WKS TRTMT OF VILDAGLIPTIN,EXENATIDE, OR COMBINATION
-
批准号:7718698
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
REACTIVE OXYGEN SPECIES (ROS), MITOCHONDRIAL DYSFUNCTION AND T2D (PROT 1)
-
批准号:7718693
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
MECHANISM OF INSULIN SENSITIZING EFFECT OF PIOGLITAZONE-ROLE OF ADIPONECTIN
-
批准号:7718694
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
IS NON-DIABETIC FASTING HYPERGLYCEMIA EXPLAINED BY IMPAIRED GLUCOSE UPTAKE
-
批准号:7718703
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:RALPH A DEFRONZO
-
依托单位:
海外基金